Esophageal cancer echocardiography and ultrasound

Jump to navigation Jump to search

Esophageal cancer Microchapters


Patient Information


Historical Perspective



Differentiating Esophageal cancer from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings



Echocardiography and Ultrasound



Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal cancer echocardiography and ultrasound On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Esophageal cancer echocardiography and ultrasound

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal cancer echocardiography and ultrasound

CDC on Esophageal cancer echocardiography and ultrasound

Esophageal cancer echocardiography and ultrasound in the news

Blogs on Esophageal cancer echocardiography and ultrasound

Directions to Hospitals Treating Esophageal cancer

Risk calculators and risk factors for Esophageal cancer echocardiography and ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]


There are no echocardiography findings associated with esophageal cancer. However, an endoscopic ultrasound may be helpful in staging of esophageal cancer showing location, spread and resectability.


Endoscopic Ultrasound[4] Sensitivity Specificity
Detection of celiac lymph nodes metastases 85% 96%
Detection of regional lymph node metastases 80% 70%
Shows a mass detected on endoscopy (blue arrow) and the same mass is viewed using endoscopic ultrasound (yellow arrow). Source: by Samir at the English language Wikipedia, CC BY-SA 3.0,


  1. Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L (2000). "Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma". J. Clin. Oncol. 18 (18): 3202–10. doi:10.1200/JCO.2000.18.18.3202. PMID 10986052.
  2. Keswani RN, Early DS, Edmundowicz SA, Meyers BF, Sharma A, Govindan R, Chen J, Kohlmeier C, Azar RR (2009). "Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer". Gastrointest. Endosc. 69 (7): 1210–7. doi:10.1016/j.gie.2008.08.016. PMID 19012886.
  3. Tio TL, Coene PP, den Hartog Jager FC, Tytgat GN (1990). "Preoperative TNM classification of esophageal carcinoma by endosonography". Hepatogastroenterology. 37 (4): 376–81. PMID 2210603.
  4. van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD (2008). "Staging investigations for oesophageal cancer: a meta-analysis". Br. J. Cancer. 98 (3): 547–57. doi:10.1038/sj.bjc.6604200. PMC 2243147. PMID 18212745.

Template:WikiDoc Sources